← TFL Tables: Adverse Events

Lesson number Lesson SASRSAS VideoR Video
TFL_TAE_L100Overview of Adverse Events
TFL_TAE_L101Treatment emergent adverse events, by primary system organ class and preferred term
TFL_TAE_L102Treatment-Emergent Adverse Events by Severity
TFL_TAE_L103Treatment-Emergent Adverse Events by descending frequency
TFL_TAE_L103aTreatment-Emergent Adverse Events by descending frequency - SOC repeated on page
TFL_TAE_L103bTreatment-Emergent Adverse Events by descending frequency - SOC repeated - approach 2
TFL_TAE_L104Treatment-Emergent Adverse Events by Relationship to Study Drug
TFL_TAE_L105Treatment-Emergent Adverse Events by Preferred Term
TFL_TAE_L105aTreatment-Emergent Adverse Events by Preferred Term
TFL_TAE_L105a1Treatment-Emergent Adverse Events by Preferred Term (descending frequency)
TFL_TAE_L106TEAE That Equal to or Exceed a Threshold of 5% in Any Treatment Group
TFL_TAE_L107Treatment-Emergent Adverse Events by Preferred Term - with fisher exact test p-value
TFL_TAE_L107aTEAE by PT - with chisq/fisher exact test p-value
TFL_TAE_L108TEAE by PT - Odds Ratio
TFL_TAE_L108aTEAE by PT - Odds Ratio with p-value
TFL_TAE_L109TEAE by PT - Risk Ratio
TFL_TAE_L110TEAE by PT - Risk Difference
TFL_TAE_L111Exposure Adjusted Event Rate by SOC and PT
TFL_TAE_L112Exposure Adjusted Subject Incidence Rate by SOC and PT
TFL_TAE_L113TEAE by SOC, PT and Grade